Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study - Smits, ML; Nijsen, JF; Bosch, MA van den (Lancet Oncol, 2012)
et al.